Delivery Order SPE2DB22D3004-SPE2DB25FSD85
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Lidocaine 5% Patch in quantities of 30 units, with a ceiling value of $10,360.64. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award carries an ultimate completion date of August 11, 2025,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lidocaine 5% Patch 30-count units, with a ceiling value of $10,232.40. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Lidocaine 5% patches (30-count) with a ceiling value of $120,742.35. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX. The award was competitively awarded with no set-aside provisions....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,727.04 on August 21, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is a child contract with an ultimate completion date of August 22, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, allowing AmerisourceBergen to compete openly for this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lidocaine 5% Patch 30s at a ceiling value of $6,861.83. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order is scheduled for completion by August 14, 2025,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for Lidocaine 5% Patch 30-count units with a ceiling value of $3,936.42. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $8,028.28. This competitively awarded, non-set-aside order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order carries a firm fixed price structure with an ultimate completion date...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,143.54 for Lidocaine 5% Patch 30-count units on May 19, 2025, with completion scheduled for May 20, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The delivery will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $1,721.54 and a completion date of September 2, 2025. This delivery order was competitively awarded without a set-aside designation and structured as a firm fixed-price contract with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $1,509.44. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is a child contract issued...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSD85Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lidocaine 5% Patch (30-count units) under a firm fixed-price arrangement with a ceiling value of $1,412.04. The contract, which is not set-aside and was competitively awarded, represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This underlying prime IDV, designated SPE2DX and valued at $999,999,999.00 through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, functions as a critical vendor for federal medical procurement serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply needs ranging from small-value transactions to substantial orders. The Lidocaine patch delivery order fulfills DLA's pain management pharmaceutical requirements, with performance scheduled for completion by August 26, 2025, at the vendor's Conshohocken facility.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/25/25 |